Monday, March 5, 2012

SUPPLY AND DEMAND - Case study: Tamiflu.(production data of Tamiflu medicine)

The influenza virus kills 500,000 worldwide every year. Last year in the US, nearly 40,000 people died of the disease, exceeding epidemic status. Flu is considered such a serious threat to health that most countries routinely vaccinate the elderly and those with weak immune systems. Now the prospect of an avian flu pandemic* is causing whole nations to question whether they have enough medication to fight the illness. Swiss pharmaceutical company, Roche, is the owner of the world's best known flu medicine - Tamiflu.

Supply concerns

The company enjoys the reputation of being a leader in its field. However, this reputation has also made it the target for …

No comments:

Post a Comment